Protocol for treatment of diabetic foot ulcers

被引:121
作者
Brem, H
Sheehan, P
Boulton, AJM
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Surg, New York, NY 10034 USA
[2] Hosp Joint Dis & Med Ctr, Diabet Foot & Ankle Ctr, New York, NY USA
[3] Univ Miami, Sch Med, Div Endocrinol, Miami, FL 33152 USA
[4] Univ Manchester, Manchester, Lancs, England
关键词
D O I
10.1016/S0002-9610(03)00299-X
中图分类号
R61 [外科手术学];
学科分类号
摘要
Each year, 82.000 limb amputations are performed in patients with diabetes mellitus. The majority of these amputations could be avoided by following strict protocols. The collective experience treating patients with neuropathic diabetic foot ulcers of 4 major diabetic foot programs in the United States and Europe were analyzed. The following protocol has been developed for patients with diabetic foot ulcers: (1) measurement of the wound by planimetry; (2) optimal glucose control; (3) surgical debridement of all hyperkeratotic, infected, and nonviable tissue; (4) systemic antibiotics for deep infection, drainage, and cellulitis; (5) offloading; (6) moist-wound environment; and (7) treatment with growth factors and/or cellular therapy if the wound is not healing after 2 weeks with this protocol and a new epithelial layer is not forming. In addition, the pathogenesis of diabetic foot ulcers is discussed, as well as the associated costs and complications, including amputation. Debridement. wound-bed preparation, antibiotics, various types of dressings, biological therapies, growth factors, and offloading are described as treatment modalities for patients with diabetic foot ulcers. In diabetic foot ulcers, availability of the above modalities, in combination with early recognition and comprehensive treatment, ensure rapid healing and minimize morbidity, mortality, and costs, as well as eliminate amputation in the absence of ischemia and osteomyelitis. (C) 2004 Excerpta Medica, Inc. All rights reserved.
引用
收藏
页码:1S / 10S
页数:10
相关论文
共 74 条
[1]   Lower-extremity amputation in diabetes - The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers [J].
Adler, AI ;
Boyko, EJ ;
Ahroni, JH ;
Smith, DG .
DIABETES CARE, 1999, 22 (07) :1029-1035
[2]  
[Anonymous], [No title captured]
[3]  
Apelqvist J, 2000, DIABETES-METAB RES, V16, pS84, DOI 10.1002/1520-7560(200009/10)16:1+<::AID-DMRR113>3.0.CO
[4]  
2-S
[5]   Off-loading the diabetic foot wound - A randomized clinical trial [J].
Armstrong, DG ;
van Schie, CHM ;
Nguyen, HC ;
Boulton, AJM ;
Lavery, LA ;
Harkless, LB .
DIABETES CARE, 2001, 24 (06) :1019-1022
[6]   Technique for fabrication of an "instant total-contact cast" for treatment of neuropathic diabetic foot ulcers [J].
Armstrong, DG ;
Short, B ;
Espensen, EH ;
Abu-Rumman, PL ;
Nixon, BP ;
Boulton, AJM .
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2002, 92 (07) :405-408
[7]   Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization [J].
Arora, S ;
Pomposelli, F ;
LoGerfo, FW ;
Veves, A .
JOURNAL OF VASCULAR SURGERY, 2002, 35 (03) :501-505
[8]   Prevalence of osteomyelitis in non-healing diabetic foot ulcers:: usefulness of radiologic and scintigraphic findings [J].
Balsells, M ;
Viadé, J ;
Millán, M ;
García, JR ;
García-Pascual, L ;
del Pozo, C ;
Anglada, J .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1997, 38 (02) :123-127
[9]  
Becker W, 1999, Q J NUCL MED, V43, P9
[10]  
BESSMAN AN, 1996, J DIABETES COMPLICAT, V4, P258